• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾功能与慢性心力衰竭患者血清心肌肌钙蛋白 T 的关系。

Relationship between renal function and serum cardiac troponin T in patients with chronic heart failure.

机构信息

Department of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Tsukinowa, Seta, Otsu 520-2192, Japan.

出版信息

Eur J Heart Fail. 2009 Jul;11(7):653-8. doi: 10.1093/eurjhf/hfp072. Epub 2009 Jun 5.

DOI:10.1093/eurjhf/hfp072
PMID:19502379
Abstract

AIMS

Both serum cardiac troponin T (cTnT) and renal function are prognostic predictors in patients with chronic heart failure (CHF). We aimed to evaluate the relationship between renal function and serum cTnT.

METHODS AND RESULTS

We measured serum concentrations of cTnT in the aortic root (AO) and coronary sinus (CS) in 258 CHF patients. Patients were divided into two groups: patients with an estimated glomerular filtration rate (eGFR) >or= 60 mL/min/1.73 m(2) [chronic kidney disease (CKD)(-)], and patients with an eGFR < 60 mL/min/1.73 m(2) [CKD (+)]. In 32 (12%) of the 258 CHF patients, serum levels of cTnT were detectable (>or=0.03 ng/mL) in the AO and in the CS. There was no correlation between eGFR and the transcardiac increase in cTnT and there was a significant negative correlation between eGFR and the serum cTnT concentration (r = - 0.365, P = 0.039). There was no difference in the transcardiac gradient of cTnT between patients without CKD (n = 16) and patients with CKD (n = 16) (0.083 +/- 0.11 vs. 0.108 +/- 0.13 ng/mL, P = 0.55). However, the serum cTnT level in the AO was two-fold higher in CHF patients with CKD than patients without CKD (0.20 +/- 0.177 vs. 0.088 +/- 0.065 ng/mL, P < 0.05).

CONCLUSION

These findings indicate that decreased clearance via the kidney contributes to the elevated cTnT in CHF patients with CKD.

摘要

目的

血清心肌肌钙蛋白 T(cTnT)和肾功能都是慢性心力衰竭(CHF)患者的预后预测指标。本研究旨在评估肾功能与血清 cTnT 之间的关系。

方法和结果

我们在 258 例 CHF 患者中测量了主动脉根部(AO)和冠状窦(CS)的血清 cTnT 浓度。患者分为两组:肾小球滤过率(eGFR)≥60 mL/min/1.73 m²[慢性肾脏病(CKD)(-)]和 eGFR<60 mL/min/1.73 m²[CKD(+)]。在 258 例 CHF 患者中,有 32 例(12%)的 AO 和 CS 中可检测到血清 cTnT 水平(≥0.03 ng/mL)。eGFR 与跨心 cTnT 增加之间无相关性,eGFR 与血清 cTnT 浓度呈显著负相关(r = -0.365,P = 0.039)。无 CKD 患者(n = 16)和 CKD 患者(n = 16)之间的 cTnT 跨心梯度无差异(0.083 ± 0.11 对 0.108 ± 0.13 ng/mL,P = 0.55)。然而,CKD 的 CHF 患者的 AO 中的血清 cTnT 水平是无 CKD 患者的两倍(0.20 ± 0.177 对 0.088 ± 0.065 ng/mL,P<0.05)。

结论

这些发现表明,肾脏清除能力下降导致 CKD 的 CHF 患者 cTnT 升高。

相似文献

1
Relationship between renal function and serum cardiac troponin T in patients with chronic heart failure.肾功能与慢性心力衰竭患者血清心肌肌钙蛋白 T 的关系。
Eur J Heart Fail. 2009 Jul;11(7):653-8. doi: 10.1093/eurjhf/hfp072. Epub 2009 Jun 5.
2
Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.胱抑素C、N末端前B型利钠肽和心肌肌钙蛋白T在急性心力衰竭患者中的补充预后价值。
Am J Cardiol. 2009 Jun 15;103(12):1753-9. doi: 10.1016/j.amjcard.2009.02.029.
3
Circulating N-terminal pro-brain natriuretic peptide and cardiac troponin T in chronic dialysis patients.慢性透析患者的循环N末端脑钠肽前体和心肌肌钙蛋白T
J Med Assoc Thai. 2003 May;86 Suppl 1:S52-8.
4
Do cardiac troponins provide prognostic insight in hemodialysis patients?心肌肌钙蛋白能否为血液透析患者提供预后信息?
Can J Cardiol. 2003 Jul;19(8):907-11.
5
Cardiac troponin T as a prognostic marker in patients with heart failure : a 3-year outcome study.心肌肌钙蛋白T作为心力衰竭患者的预后标志物:一项3年随访研究
Angiology. 2007 Oct-Nov;58(5):603-9. doi: 10.1177/0003319707307344.
6
Heart-type fatty acid-binding protein is more sensitive than troponin T to detect the ongoing myocardial damage in chronic heart failure patients.在检测慢性心力衰竭患者正在发生的心肌损伤方面,心脏型脂肪酸结合蛋白比肌钙蛋白T更敏感。
J Card Fail. 2007 Mar;13(2):120-7. doi: 10.1016/j.cardfail.2006.10.014.
7
Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.肾功能、充血性心力衰竭与氨基末端脑钠肽前体测定:急诊科呼吸困难的脑钠肽前体研究(PRIDE)结果
J Am Coll Cardiol. 2006 Jan 3;47(1):91-7. doi: 10.1016/j.jacc.2005.08.051. Epub 2005 Dec 9.
8
Prognostic value of cardiac troponin T elevation is independent of renal function and clinical findings in heart failure patients.在心力衰竭患者中,心肌肌钙蛋白 T 升高的预后价值与肾功能和临床发现无关。
Cardiol J. 2010;17(1):42-8.
9
Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over time.慢性心力衰竭门诊患者的系列生物标志物测量:随时间变化的重要性。
Circulation. 2007 Jul 17;116(3):249-57. doi: 10.1161/CIRCULATIONAHA.107.694562. Epub 2007 Jun 25.
10
Relationship between renal function and plasma brain natriuretic peptide in patients with heart failure.心力衰竭患者肾功能与血浆脑钠肽的关系
J Am Coll Cardiol. 2006 Feb 7;47(3):582-6. doi: 10.1016/j.jacc.2005.10.038. Epub 2006 Jan 18.

引用本文的文献

1
Serum High-Sensitivity Cardiac Troponin T as an Independent Predictor for Incident Coronary Heart Disease in the Japanese General Population: The Circulatory Risk in Communities Study (CIRCS).血清高敏心肌肌钙蛋白 T 作为日本一般人群中冠心病事件的独立预测因子:社区中的循环风险研究 (Circulatory Risk in Communities Study, CIRCS)。
J Atheroscler Thromb. 2023 Mar 1;30(3):237-246. doi: 10.5551/jat.63378. Epub 2022 May 15.
2
Elevation of Highly Sensitive Cardiac Troponin T Among End-Stage Renal Disease Patients Without Acute Coronary Syndrome.无急性冠状动脉综合征的终末期肾病患者中高敏心肌肌钙蛋白T升高
Malays J Med Sci. 2021 Oct;28(5):64-71. doi: 10.21315/mjms2021.28.5.6. Epub 2021 Oct 26.
3
Efficacy of Statin Treatment According to Baseline Renal Function in Korean Patients with Acute Myocardial Infarction Not Requiring Dialysis Undergoing Newer-Generation Drug-Eluting Stent Implantation.
韩国急性心肌梗死且无需透析的患者在接受新一代药物洗脱支架植入时,他汀类药物治疗依据基线肾功能的疗效。
J Clin Med. 2021 Aug 9;10(16):3504. doi: 10.3390/jcm10163504.
4
Potential relationship between eGFR /eGFR -ratio and glomerular basement membrane thickness in diabetic kidney disease.糖尿病肾病中估算肾小球滤过率(eGFR)/eGFR比值与肾小球基底膜厚度之间的潜在关系。
Physiol Rep. 2021 Jul;9(13):e14939. doi: 10.14814/phy2.14939.
5
Well-Known and Novel Serum Biomarkers for Risk Stratification of Patients with Non-ischemic Dilated Cardiomyopathy.非缺血性扩张型心肌病患者风险分层的知名和新型血清生物标志物。
Int J Mol Sci. 2021 May 26;22(11):5688. doi: 10.3390/ijms22115688.
6
Expert consensus on the monitoring of transthyretin amyloid cardiomyopathy.关于转甲状腺素蛋白淀粉样心肌病监测的专家共识。
Eur J Heart Fail. 2021 Jun;23(6):895-905. doi: 10.1002/ejhf.2198. Epub 2021 May 24.
7
Fibroblast growth factor 23: a biomarker of fibrosis and prognosis in heart failure with preserved ejection fraction.成纤维细胞生长因子 23:射血分数保留的心力衰竭中纤维化和预后的生物标志物。
ESC Heart Fail. 2020 Oct;7(5):2494-2507. doi: 10.1002/ehf2.12816. Epub 2020 Jun 24.
8
The Value of a Cystatin C-based Estimated Glomerular Filtration Rate for Cardiovascular Assessment in a General Japanese Population: Results From the Iwate Tohoku Medical Megabank Project.胱抑素 C 估算肾小球滤过率在日本一般人群心血管评估中的价值:岩手东北医疗巨型数据库项目的结果。
J Epidemiol. 2020 Jun 5;30(6):260-267. doi: 10.2188/jea.JE20180274. Epub 2019 May 25.
9
Impact of renal dysfunction on the management and outcome of acute heart failure: results from the French prospective, multicentre, DeFSSICA survey.肾功能不全对急性心力衰竭管理和预后的影响:来自法国前瞻性、多中心、DeFSSICA 调查的结果。
BMJ Open. 2019 Jan 15;9(1):e022776. doi: 10.1136/bmjopen-2018-022776.
10
sST2 as a New Biomarker of Chronic Kidney Disease-Induced Cardiac Remodeling: Impact on Risk Prediction.sST2 作为慢性肾脏病引起的心脏重构的新型生物标志物:对风险预测的影响。
Mediators Inflamm. 2018 Oct 8;2018:3952526. doi: 10.1155/2018/3952526. eCollection 2018.